Incyte CEO on New Drugs, Jakafi Applications

Incyte CEO on New Drugs, Jakafi Applications Play

Feb. 20 (Bloomberg) -- Herve Hoppenot, chief executive officer of Incyte Corp., talks with Bloomberg’s Meg Tirrell about the company's Jakfi drug used to treat a bone marrow disorder called myelofibrosis, Incyte's drug pipeline and the outlook for growth. Shares of the cancer-drug maker have tripled in the last year. (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    Money Clip Watch Now

  • Next

    Charlie Rose

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus